Discuss cutting-edge small molecule strategies capable of interacting with and modulating RNA with improved specificity, selectivity and drug-like properties.
Digital Event
Joined August 2019
- Tweets83
- Following281
- Followers313
- Likes2
It's our earlybird savings week for both the 2nd TPD Europe Summit & 4th RNA Targeted Drug Discovery Summit. Register this week to save on your place! Bring your team & get additional group savings of up to 20%!
RNA: bit.ly/3wzKcc6
TPD Europe: bit.ly/3F9kuhA
Did you know at the 4th RNA Targeted Drug Discovery Summit we have 3 comprehensive, deep-dive collaborative workshop sessions as well as our 2-day conference? Find out more here: ter.li/pj6jo6
Check out the 2021 agenda for the RNA Targeted Drug Discovery Summit taking place virtually this December!
3 days of content, 160+ attendees and counting, expert speakers from @AnimaBiotech, @rnarevealed, @expansionrx & many more!
bit.ly/3uRRbw8
RNA-Targeted Drug Discovery Summit retweeted
Wesley Blackaby, VP Chemistry will be participating @RNA_TDD Summit! He'll be discussing 'Drugging #RNA modifying #enzymes' today at 11:30am EST rna-drugdiscovery.com
RNA-Targeted Drug Discovery Summit retweeted
Have you seen this year's event guide for the 3rd RNA- Targeted Drug Discovery Summit yet? Find out who this year’s expert speakers are and everything that they will be discussing - access your free copy here: ter.li/4b9l21
We caught up with our speakers from @ArrakisTx, Saverna Therapeutics & @abbvie to find out more about their #RNA work, the challenges the field is facing and where the biggest opportunities lie as the field progresses! Access the full interviews here: ter.li/tljhky
RNA-Targeted Drug Discovery Summit retweeted
COVID messenger-RNA vaccine: Early findings in older adults. Moderna vax now tested w/ 2 doses in 40 people 55 & up; mean age 69. No serious adverse events noted thru 57 days. A few symptoms: headache, injection-site pain. Vax officially known as mRNA-1273 jwatch.org/na52577/2020/10/0…
RNA-Targeted Drug Discovery Summit retweeted
Direct measurements of mRNA translation kinetics in living cells
biorxiv.org/cgi/content/shor…
Will you be joining us this December? We hope so! And as such we want you to know that you can save $560 on your pass this week ONLY. Offer ends at midnight tomorrow - don't miss out! ter.li/9bv20v
Shoutout to the recent additions to the 2020 delegate list! With over 100 #RNA experts now in the room, this is shaping up to be quite a meeting. Get involved: ter.li/2sftfx
Panel Discussion: From Theory to Reality: How to Target RNA Biology with Small Molecule Approaches. Join @ArrakisTx, @AnimaBiotech & @LillyPad to discuss successful methods, utilize industry achievements & overcome key challenges. Find out more: ter.li/uo0kao
Learn how @scrippsresearch, @Roche, @ArrakisTx and more are advancing their #RNA targeted small molecule therapeutics & gain insight into translating RNA targeted small molecule discoveries into clinical development. Full speaker line-up and agenda here: ter.li/f4kbje
RNA-Targeted Drug Discovery Summit retweeted
An interesting difference between the Moderna and Pfizer mRNA vaccines. Moderna RNA is more stable at temperatures of +4 to -20 degrees Celsius whereas the Pfizer vaccine needs to be maintained at -80 which will significantly limit distribution. theatlantic.com/health/archi…
Save $805 on your pass to this year's Summit! Saving expires at midnight tonight - access yours here: ter.li/m43dps
This week ONLY you can save $805 on your ticket to this year's summit. But did you know that you can access extra discounts ON TOP OF this saving when you register as a group? Claim yours today: ter.li/8wo1i6
Can't wait to hear more from Jen Petter and @ArrakisTx in December!
Our CSO, Jen Petter, offers a Dark Matter Blog post that chronicles how a small molecule drug just approved by FDA, #risdiplam, is able to bind to RNA to treat spinal muscular atrophy #SMA, stepping onto the stage with oligo and gene therapy drugs. arrakistx.com/a-new-drug-app…
RNA-Targeted Drug Discovery Summit retweeted
Unlocking the power of machine learning for small molecule drug discovery
swisscognitive.ch/2020/07/01…
RNA-Targeted Drug Discovery Summit retweeted
Prelude Therapeutics gets $50M Series C funding to support Prelude’s oncological research focused on using small-molecule inhibitors as a cancer therapy. Meet Kris Vaddi, founder and CEO
delawarebusinesstimes.com/ne…